PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $87,000 | -57.6% | 195,136 | 0.0% | 0.01% | -57.1% |
| Q1 2016 | $205,000 | +26.5% | 195,136 | +254.8% | 0.03% | +33.3% |
| Q4 2015 | $162,000 | +376.5% | 55,000 | +414.3% | 0.02% | +320.0% |
| Q3 2015 | $34,000 | -78.8% | 10,695 | -37.1% | 0.01% | -78.3% |
| Q4 2014 | $160,000 | -22.7% | 17,000 | -26.4% | 0.02% | -39.5% |
| Q2 2014 | $207,000 | – | 23,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |